BioWorld-International-2005-10-12
Alzheimer's Drugs Could Follow New Breakthrough
Novexel Begins Phase I Trial, Gathers In Milestone Payment
PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections. (BioWorld International)

